Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Abramson Cancer Center at Penn Medicine
University of California, Irvine
OHSU Knight Cancer Institute
Daiichi Sankyo
Tempus AI
British Columbia Cancer Agency
Apollomics Inc.
University of California, Irvine
Elevation Oncology
Zhejiang Provincial People's Hospital
Rutgers, The State University of New Jersey
Sun Yat-sen University
National Institutes of Health Clinical Center (CC)
Nottingham University Hospitals NHS Trust
Amgen
Sound Pharmaceuticals, Incorporated
Wake Forest University Health Sciences
Roswell Park Cancer Institute
Novartis
Dana-Farber Cancer Institute
Papworth Hospital NHS Foundation Trust
Alliance for Clinical Trials in Oncology
GE Healthcare
GE Healthcare
Siemens Molecular Imaging
National Cancer Institute (NCI)
Barbara Ann Karmanos Cancer Institute
Fox Chase Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Northwestern University
Hoag Memorial Hospital Presbyterian